HIV infection results in CD4+ T cell deficiency, but efficient combination antiretroviral therapy (c-ART) restores T cells and decreases morbidity and mortality. However, immune restoration by c-ART remains variable, and prolonged T cell deficiency remains in a substantial proportion of patients. In a prospective open-label phase I/IIa trial, we evaluated the safety and efficacy of administration of the T cell regulator IL-7. The trial included 13 c-ART–treated HIV-infected patients whose CD4+ cell counts were between 100 and 400 cells/μl and plasma HIV RNA levels were less than 50 copies/ml. Patients received a total of 8 subcutaneous injections of 2 different doses of recombinant human IL-7 (rhIL-7; 3 or 10 μg/kg) 3 times per week over a 16-day period. rhIL-7 was well tolerated and induced a sustained increase of naive and central memory CD4+ and CD8+ T cells. In the highest dose group, 4 patients experienced transient increases in viral replication. However, functional assays showed that the expanded T cells responded to HIV antigen by producing IFN-γ and/or IL-2. In conclusion, in lymphopenic HIV-infected patients, rhIL-7 therapy induced substantial functional and quantitative changes in T cells for 48 weeks. Therefore, patients may benefit from intermittent therapy with IL-7 in combination with c-ART.
Yves Levy, Christine Lacabaratz, Laurence Weiss, Jean-Paul Viard, Cecile Goujard, Jean-Daniel Lelièvre, François Boué, Jean-Michel Molina, Christine Rouzioux, Véronique Avettand-Fénoêl, Thérèse Croughs, Stéphanie Beq, Rodolphe Thiébaut, Geneviève Chêne, Michel Morre, Jean-François Delfraissy
Title and authors | Publication | Year |
---|---|---|
Cumulative Mechanisms of Lymphoid Tissue Fibrosis and T Cell Depletion in Immunodeficiency Virus Infections
Ming Zeng, Anthony Smith, Stephen Wietgrefe, Peter Southern, Timothy Schacker, Cavan Reilly, Jacob Estes, Gregory Burton, Guido Silvestri, Jeffrey Lifson, John Carlis, Ashley Haase |
Journal of Clinical Investigation | 2011 |
Interleukin-7 inhibits tumor-induced CD27−CD28− suppressor T-cells: implications for cancer immunotherapy
Y Zhang, LW Pfannenstiel, E Bolesta, CL Montes, X Zhang, AI Chapoval, RB Gartenhaus, SE Strome, BR Gastman |
Clinical cancer research | 2011 |
HIV controllers: A multifactorial phenotype of spontaneous viral suppression
J Thèze, LA Chakrabarti, B Vingert, F Porichis, DE Kaufmann |
Clinical Immunology | 2011 |
Harnessing the biology of IL-7 for therapeutic application
CL Mackall, TJ Fry, RE Gress |
Nature Reviews Immunology | 2011 |
HIV-1 viruses detected during episodic blips following interleukin-7 administration are similar to the viruses present before and after interleukin-7 therapy:
H Imamichi, G DeGray, DM Asmuth, MA Fischl, AL Landay, MM Lederman, I Sereti |
AIDS | 2011 |
Finding a cure for HIV: will it ever be achievable?
SR Lewin, VA Evans, JH Elliott, B Spire, N Chomont |
Journal of the International AIDS Society | 2011 |
Immunotherapeutic effects of IL-7 during a chronic viral infection in mice
SG Nanjappa, EH Kim, M Suresh |
Blood | 2011 |
Interleukin-21 administration to rhesus macaques chronically infected with simian immunodeficiency virus increases cytotoxic effector molecules in T cells and NK cells and enhances B cell function without increasing immune activation or viral replication
S Pallikkuth, K Rogers, F Villinger, M DosterII, M Vaccari, G Franchini, R Pahwa, S Pahwa |
Vaccine | 2011 |
True story about HIV: theory of viral sequestration and reserve infection
SS Barasa |
HIV/AIDS (Auckland, N.Z.) | 2011 |
IL-7 Promotes CD95-Induced Apoptosis in B Cells via the IFN-γ/STAT1 Pathway
S Sammicheli, VP Dang, N Ruffin, HT Pham, R Lantto, N Vivar, F Chiodi, B Rethi |
PloS one | 2011 |
Immunosuppression in Patients Who Die of Sepsis and Multiple Organ Failure
JS Boomer, K To, KC Chang, O Takasu, DF Osborne, AH Walton, TL Bricker, SD 2nd, D Kreisel, AS Krupnick, A Srivastava, PE Swanson, JM Green, RS Hotchkiss |
Journal of the American Medical Association | 2011 |
Factors associated with paradoxical immune response to antiretroviral therapy in HIV infected patients: a case control study
JA Casotti, LN Passos, FJ Oliveira, C Cerutti |
BMC Infectious Diseases | 2011 |
Advances in the management of sepsis and the understanding of key immunologic defects
LP Skrupky, PW Kerby, RS Hotchkiss |
Anesthesiology | 2011 |
Validation of a gene expression-based subclassification strategy for pediatric septic shock
HR Wong, NZ Cvijanovich, GL Allen, NJ Thomas, RJ Freishtat, N Anas, K Meyer, PA Checchia, R Lin, TP Shanley, MT Bigham, DS Wheeler, LA Doughty, K Tegtmeyer, SE Poynter, JM Kaplan, RS Chima, E Stalets, RK Basu, BM Varisco, FE Barr |
Critical Care Medicine | 2011 |
Improved survival of HIV-1-infected patients with progressive multifocal leukoencephalopathy receiving early 5-drug combination antiretroviral therapy.
Gasnault J, Costagliola D, Hendel-Chavez H, Dulioust A, Pakianather S, Mazet AA, de Goer de Herve MG, Lancar R, Lascaux AS, Porte L, Delfraissy JF, Taoufik Y |
PloS one | 2011 |